Stocks HXHX Financial statements
Financial statementsHaoxin Holdings Ltd financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Haoxin Holdings Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Revenue | 28.9 | 26.7 | 25.6 | 33 |
| Cost of revenue | 21.2 | 19.8 | 19.1 | 24.7 |
| Gross profit | 7.74 | 6.86 | 6.49 | 8.3 |
| Selling and marketing | 0.09 | 0.09 | 0.08 | 0.05 |
| General and administrative | 1.44 | 0.76 | 0.87 | 0.45 |
| Operating income | 6.21 | 6.01 | 5.54 | 7.79 |
| Interest expense | 0.17 | 0.15 | 0.19 | 0.27 |
| Other non-operating income | -0.28 | -0.5 | -0.95 | -2.1 |
| Pre-tax income | 5.92 | 5.5 | 4.59 | 5.69 |
| Income tax | 1.64 | 1.53 | 1.42 | 1.72 |
| Net income | 4.29 | 3.97 | 3.17 | 3.97 |
| EBITDA | 7.07 | 6.56 | 5.93 | 8.1 |
| EPS, basic | 0.36 | 0.33 | 0.26 | 0.30 |
| EPS, diluted | 0.36 | 0.33 | 0.26 | 0.30 |
| Shares, basic (weighted) | 12 | 12 | 12 | 13.2 |
| Shares, diluted (weighted) | 12 | 12 | 12 | 13.2 |
Balance sheet
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Cash and equivalents | 0.1 | 0.09 | 0.17 | 1.4 |
| Receivables | 17.7 | 19.1 | 8.78 | |
| Other current assets | 5.51 | 0.03 | 0.02 | |
| Total current assets | 26.5 | 31.1 | 45.8 | |
| Property, plant and equipment | 0.89 | 0.54 | 4.35 | |
| Lease right-of-use assets | 0.01 | 0 | ||
| Other non-current assets | 0.79 | 0.79 | 0.13 | |
| Total assets | 28.1 | 32.4 | 50.3 | |
| Accounts payable | 1.27 | 0.61 | 0.11 | |
| Short-term debt | 2.29 | 2.49 | 7.79 | |
| Total current liabilities | 12.1 | 13.9 | 19.3 | |
| Lease liabilities | 0 | |||
| Total liabilities | 12.5 | 14 | 22.6 | |
| Total debt | 0.95 | 0.48 | ||
| Paid-in capital | 2.96 | 2.96 | 7.16 | |
| Retained earnings | 12.7 | 15.9 | 19.9 | |
| Other comprehensive income | -0.89 | -1.39 | -0.3 | |
| Shareholders' equity | 12.1 | 15.7 | 18.4 | 27.6 |
| Total equity | 12.1 | 15.7 | 18.4 | 27.6 |
| Total liabilities and equity | 28.1 | 32.4 | 50.3 |
Cash flow statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Net income | 4.29 | 3.97 | 3.17 | 3.97 |
| Depreciation and amortization | 0.86 | 0.55 | 0.39 | 0.31 |
| Deferred income tax | -0.05 | 0.02 | -0.01 | 0.07 |
| Change in receivables | 0.12 | -5.7 | -2 | 10.3 |
| Change in payables | -1.52 | 0.26 | -0.64 | -0.32 |
| Cash from operations | -0.43 | 0.93 | -3.96 | -9.55 |
| Capital expenditures | -0.07 | -0.01 | -0 | -4.48 |
| Cash from investing | -0.07 | -0.01 | 1 | -9.39 |
| Debt repaid | -0.15 | -0.09 | ||
| Cash from financing | -0.13 | -0.94 | 3.05 | 20.2 |
| Exchange rate effect | -0.04 | -0 | -0 | -0.05 |
| Net change in cash | -0.68 | -0.01 | 0.08 | 1.23 |
| Free cash flow | -0.5 | 0.92 | -3.96 | -14 |
| Interest paid | 0.17 | 0.15 | 0.18 | 0.26 |
| Income taxes paid | 0.17 | 0.03 | 0.07 | 0.17 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 25.1% | Gross profit / revenue. |
| Operating margin | 23.6% | Operating income / revenue. |
| EBITDA margin | 24.5% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 17.2% | Pre-tax income / revenue. |
| Net margin | 12.0% | Net income / revenue. |
| FCF margin | -42.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -28.9% | Cash from operations / revenue. |
| Effective tax rate | 30.3% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 17.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 9.6% | Net income / average total assets. |
| Return on invested capital (ROIC) | 24.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Capex / revenue | 13.6% | Capital expenditures / revenue. |
| D&A / revenue | 0.9% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 29.2% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 4.5% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 27.9% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 2.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 40.6% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 7.9% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 36.5% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 4.6% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | 25.0% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -2.5% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 15.4% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -5.9% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 50.4% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 31.7% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 55.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Share count change, 1y | 10.4% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 3.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.37x | Current assets / current liabilities. |
| Quick ratio | 0.53x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.07x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 45.0% | Total liabilities / total assets. |
| Interest coverage | 28.9x | Operating income / interest expense. |
| Working capital | $26.5M | Current assets - current liabilities. |
| Tangible book value | $27.6M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.80x | Revenue / average total assets. |
| Fixed asset turnover | 13.5x | Revenue / average property, plant and equipment. |
| Receivables turnover | 2.37x | Revenue / average receivables. |
| Days sales outstanding | 154 days | 365 x average receivables / revenue. |
| Days payables | 5 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | -353.5% | Free cash flow / net income, when net income is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.30 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.30 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $2.49 | Revenue / diluted weighted shares. |
| FCF per share | -$1.06 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.72 | Cash from operations / diluted weighted shares. |
| Book value per share | $2.09 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $2.09 | Tangible book value / shares outstanding. |
| Cash per share | $0.11 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $5.9M | Share price x shares outstanding. |
| Enterprise value | $4.5M | Market cap + total debt - cash - short-term investments. |
| P/E | 1.49x | Market cap / net income. Only when net income is positive. |
| P/S | 0.18x | Market cap / revenue. |
| P/B | 0.21x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.21x | Market cap / tangible book value, when positive. |
| EV/Sales | 0.14x | Enterprise value / revenue. |
| EV/EBIT | 0.58x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 0.56x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -237.3% | Free cash flow / market cap. |
| Earnings yield | 67.1% | Net income / market cap (the inverse of P/E). |
What was Haoxin Holdings Ltd's revenue in fiscal 2025?
Haoxin Holdings Ltd reported revenue of $33.0M for fiscal 2025, 29.2% higher than the year before.
Was Haoxin Holdings Ltd profitable in fiscal 2025?
Yes. Net income was $4.0M, a net margin of 12%.
How much free cash flow did Haoxin Holdings Ltd generate in fiscal 2025?
Cash from operations of $9.5M minus capital expenditures of $4.5M left free cash flow of -$14.0M.